#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	15558	16S	1529	1529	99.93	16S.l6.c30.ctg.1	1922	797.1	0	.	n	.	0	C1450T	SNP	1450	1450	C	1671	1671	T	855	T,C,A	609,174,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	15558	16S	1529	1529	99.93	16S.l6.c30.ctg.1	1922	797.1	1	SNP	n	C1184T	0	.	.	1184	1184	C	1405	1405	C	959	C,T	890,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	15558	16S	1529	1529	99.93	16S.l6.c30.ctg.1	1922	797.1	0	HET	.	.	.	C1525T	.	1525	1525	C	1746	1746	C	728	C,T	508,151	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	29166	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3600	807.4	0	.	n	.	0	T695C	SNP	695	695	T	1092	1092	C	851	C,T,A	791,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	29166	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3600	807.4	0	.	n	.	0	A1638G	SNP	1638	1638	A	2035	2035	G	911	G,A	646,200	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	29166	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3600	807.4	0	.	n	.	0	T1971C	SNP	1971	1971	T	2368	2368	C	995	C	918	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	29166	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3600	807.4	1	SNP	n	A2045G	0	.	.	2045	2045	A	2442	2442	A	957	A	901	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	29166	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3600	807.4	1	SNP	n	C2597T	0	.	.	2597	2597	C	2994	2994	C	917	C	858	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	2026	folP	855	855	100.0	folP.l15.c30.ctg.1	1557	129.4	1	SNP	p	R229S	1	.	.	685	687	AGC	931	933	AGC	207;209;208	A;G;C	192;189;189	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5250	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3540	147.9	1	SNP	p	S91F	1	.	.	271	273	TTC	666	668	TTC	161;160;163	T;T;C	146;147;150	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5250	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3540	147.9	1	SNP	p	D95G	1	.	.	283	285	GGC	678	680	GGC	155;156;157	G;G;C	147;146;149	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5250	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3540	147.9	1	SNP	p	G95N	0	.	.	283	285	GGC	678	680	GGC	155;156;157	G;G;C	147;146;149	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	27	1654	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1343	122.2	1	SNP	p	G45D	0	.	.	133	135	GGC	442	444	GGC	224;221;223	G;G;C	198;195;196	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	880	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c17.ctg.1	1024	85.2	0	.	n	.	0	A197.	DEL	197	197	A	634	634	A	211	A	194	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5478	parC	2304	2304	100.0	parC.l6.c30.ctg.1	2899	187.9	1	SNP	p	D86N	0	.	.	256	258	GAC	597	599	GAC	203;203;204	G,A;A;C	181,2;184;186	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5478	parC	2304	2304	100.0	parC.l6.c30.ctg.1	2899	187.9	1	SNP	p	S87R	1	.	.	259	261	CGT	600	602	CGT	205;203;204	C,A;G;T	185,1;185;186	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5478	parC	2304	2304	100.0	parC.l6.c30.ctg.1	2899	187.9	1	SNP	p	R87W	0	.	.	259	261	CGT	600	602	CGT	205;203;204	C,A;G;T	185,1;185;186	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5478	parC	2304	2304	100.0	parC.l6.c30.ctg.1	2899	187.9	1	SNP	p	R87I	0	.	.	259	261	CGT	600	602	CGT	205;203;204	C,A;G;T	185,1;185;186	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5478	parC	2304	2304	100.0	parC.l6.c30.ctg.1	2899	187.9	1	SNP	p	S88P	0	.	.	262	264	TCC	603	605	TCC	202;202;201	T;C;C	182;182;181	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4414	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2682	163.7	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1663	1665	GGC	187;186;185	G;G;C	172;171;171	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	4352	penA	1752	1752	100.0	penA.l15.c17.ctg.1	2502	173.3	1	SNP	p	A311V	0	.	.	931	933	GCA	1334	1336	GCA	214;214;215	G;C;A	194;191;196	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4352	penA	1752	1752	100.0	penA.l15.c17.ctg.1	2502	173.3	1	SNP	p	I312M	0	.	.	934	936	ATC	1337	1339	ATC	216;217;220	A;T;C	195;199;201	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4352	penA	1752	1752	100.0	penA.l15.c17.ctg.1	2502	173.3	1	SNP	p	V316P	0	.	.	946	948	GTG	1349	1351	GTG	236;234;235	G;T;G	219;217;219	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4352	penA	1752	1752	100.0	penA.l15.c17.ctg.1	2502	173.3	1	SNP	p	V316T	0	.	.	946	948	GTG	1349	1351	GTG	236;234;235	G;T;G	219;217;219	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4352	penA	1752	1752	100.0	penA.l15.c17.ctg.1	2502	173.3	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1853	1855	ACC	239;241;241	A;C;C	212;218;221	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4352	penA	1752	1752	100.0	penA.l15.c17.ctg.1	2502	173.3	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1907	1909	GCG	234;231;229	G;C;G	201;183;194	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4352	penA	1752	1752	100.0	penA.l15.c17.ctg.1	2502	173.3	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1907	1909	GCG	234;231;229	G;C;G	201;183;194	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4352	penA	1752	1752	100.0	penA.l15.c17.ctg.1	2502	173.3	1	SNP	p	G543S	1	.	.	1627	1629	AGC	2030	2032	AGC	201;202;201	A;G;C	180;179;177	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4352	penA	1752	1752	100.0	penA.l15.c17.ctg.1	2502	173.3	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2039	2041	GGC	183;181;182	G,A;G;C	164,1;160;159	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4352	penA	1752	1752	100.0	penA.l15.c17.ctg.1	2502	173.3	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2057	2059	CCG	156;159;163	C,G;C,G;G,A	124,5;129,1;134,1	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6158	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3123	196.5	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1633	1635	CCG	210;211;212	C;C;G	183;190;186	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2404	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1888	126.8	0	.	p	.	0	M83fs	FSHIFT	247	247	A	592	592	C	180	C	157	.	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	3122	porB1b	1041	1041	98.28	porB1b.l6.c4.ctg.1	1615	191.9	0	.	p	.	0	K120N	NONSYN	358	360	AAG	794	796	AAC	243;243;242	A;A;C	228;228;227	.	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	3122	porB1b	1041	1041	98.28	porB1b.l6.c4.ctg.1	1615	191.9	0	.	p	.	0	G253Q	NONSYN	757	759	GGA	1193	1195	CAA	269;270;266	C;A;A	252;252;251	.	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	3122	porB1b	1041	1041	98.28	porB1b.l6.c4.ctg.1	1615	191.9	0	.	p	.	0	.	INDELS	760	761	AC	1197	1200	ATCA	262;259;258;256	A;T;C;A	251;250;249;249	.	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	3122	porB1b	1041	1041	98.28	porB1b.l6.c4.ctg.1	1615	191.9	0	.	p	.	0	.	MULTIPLE	764	765	AC	1205	1207	GTG	261;259;255	G;T,A;G	251;248,1;244	.	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	3122	porB1b	1041	1041	98.28	porB1b.l6.c4.ctg.1	1615	191.9	0	.	p	.	0	A257D	NONSYN	769	771	GCT	1211	1213	GAT	253;253;254	G;A,C;T	244;245,1;246	.	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	3122	porB1b	1041	1041	98.28	porB1b.l6.c4.ctg.1	1615	191.9	0	.	p	.	0	A270V	NONSYN	808	810	GCG	1250	1252	GTA	271;273;269	G;T;A	242;246;241	.	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	3122	porB1b	1041	1041	98.28	porB1b.l6.c4.ctg.1	1615	191.9	0	.	p	.	0	L277V	NONSYN	829	831	TTA	1271	1273	GTA	257;257;258	G;T;A	234;233;236	.	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	3122	porB1b	1041	1041	98.28	porB1b.l6.c4.ctg.1	1615	191.9	0	.	p	.	0	S290T	NONSYN	868	870	TCT	1310	1312	ACT	269;276;278	A,T;C;T	246,1;256;256	.	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	3122	porB1b	1041	1041	98.28	porB1b.l6.c4.ctg.1	1615	191.9	0	.	p	.	0	H292D	NONSYN	874	876	CAT	1316	1318	GAT	270;271;268	G;A,T;T	247;246,1;250	.	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	3122	porB1b	1041	1041	98.28	porB1b.l6.c4.ctg.1	1615	191.9	0	.	p	.	0	Y296H	NONSYN	886	888	TAC	1328	1330	CAC	250;251;252	C;A;C	229;232;232	.	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	3122	porB1b	1041	1041	98.28	porB1b.l6.c4.ctg.1	1615	191.9	1	SNP	p	D121N	0	.	.	361	363	GAC	797	799	GAC	244;243;245	G;A;C	230;223;226	porB1b.WHO_X_02194c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	3122	porB1b	1041	1041	98.28	porB1b.l6.c4.ctg.1	1615	191.9	1	SNP	p	A121D	1	.	.	361	363	GAC	797	799	GAC	244;243;245	G;A;C	230;223;226	porB1b.WHO_X_02194c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	10948	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4793	227.8	1	SNP	p	H553N	0	.	.	1657	1659	CAT	1956	1958	CAT	248;247;246	C;A;T	230;229;226	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1148	rpsJ	312	312	100.0	rpsJ.l6.c30.ctg.1	1055	108.3	1	SNP	p	V57M	1	.	.	169	171	ATG	548	550	ATG	256;256;258	A;T;G	232;229;232	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
